Investor AB
In its 13F for Q4 2025 (holdings as of December 31, 2025, filed February 17, 2026), Investor AB reported 12 stock positions worth $5.7 billion. Its top holding was Nasdaq (NDAQ) at 99.6% of the portfolio, followed by Mediwound (MDWD, 0.3%) and Capital One Financial (COF, 0.0%). Compared with Q3 2025, it opened 5 new positions and sold out of 5. The biggest buy was a new position in Capital One Financial (COF) and the biggest sale an exit from Microchip Technology (MCHP).
- Most Recent 13F
- Q2 2026
- Location
- STOCKHOLM, V7
- CIK
- 0000889232
- Portfolio Value
- $5.7B (Q4 2025)
- SEC Filing
- 0001493152-26-007094 ↗ filed Feb 17, 2026
Holdings Value
Holdings 12 stocks · $5.7B
| NDAQ Nasdaq Inc. | 99.60% | 58,182,426 | $5.7B | No change |
| MDWD Mediwound Ltd. | 0.28% | 872,093 | $16.1M | No change |
| COF Capital One Financial Corp. | 0.02% | 5,000 | $1.2M | New |
| COHR Coherent Corp. | 0.02% | 6,000 | $1.1M | New |
| CELLEBRITE DI LTD | 0.02% | 60,000 | $1.1M | New |
| CHKP Check Point Software Tech | 0.02% | 5,000 | $928K | No change |
| CRSR Corsair Gaming Inc. | 0.01% | 124,711 | $741K | New |
| CCL Carnival Corp. | 0.01% | 21,000 | $641K | No change |
| QBTS D-Wave Quantum Inc. | 0.01% | 15,000 | $392K | New |
| WHR Whirlpool Corp. | 0.00% | 3,700 | $267K | No change |
| BMRN Biomarin Pharmaceutical Inc. | 0.00% | 3,700 | $220K | No change |
| SSNC Ss&c Technologies Holdings | 0.00% | 2,500 | $219K | No change |
Portfolio Sells Q3 2025 → Q4 2025
Portfolio Buys Q3 2025 → Q4 2025
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 7 | $14.4B | AZN, NDAQ, MDWD, CLBT, MU |
| Q1 2026 | 10 | $15.1B | AZN, NDAQ, MDWD, CLBT, COHR |
| Q4 2025 | 12 | $5.7B | NDAQ, MDWD, COF, COHR, CELLEBRITE DI LTD |
| Q3 2025 | 12 | $5.2B | NDAQ, MDWD, MCHP, TER, CHKP |
| Q2 2025 | 13 | $5.2B | NDAQ, MDWD, MCHP, TIGO, CDNS |
| Q1 2025 | 13 | $4.4B | NDAQ, MDWD, TIGO, CDNS, MCHP |
| Q4 2024 | 8 | $4.5B | NDAQ, MDWD, CHKP, CLBT, CCL |
| Q3 2024 | 7 | $4.3B | NDAQ, MDWD, CHKP, ONTO, COHR |
| Q2 2024 | 6 | $3.5B | NDAQ, ONTO, CHKP, CCL, COHR |
| Q1 2024 | 10 | $3.7B | NDAQ, MU, AMAT, ONTO, CHKP |